Michigan Supreme Court sides with Nessel, overrules cases curtailing consumer protection law

This ruling effectively removes legal barriers that had blocked an investigation into insulin pricing practices and clears a path for future drug-pricing probes initiated by the state. The action marks a significant shift in the legal framework governing how the Attorney General may exercise regulatory oversight over various sectors of the economy. Attorney General Nessel has expressed support for the reversal, noting the restoration of state authority in these legal matters.

State Senator Singh also stated support for the ruling, framing the decision as a necessary step for consumer protection. Conversely, the NFIB has raised objections, arguing that the court's decision undermines protections previously afforded to small businesses in the state. Reporting from Crain's Grand Rapids Business emphasizes that this change potentially exposes a wide array of industries to new consumer protection lawsuits.

While the insulin investigation is a primary focus of the coverage, the broader legal implications suggest that business entities across multiple sectors may face increased regulatory scrutiny under the reinstated legal interpretation. Coverage does not yet specify the timeline for the resumption of the insulin investigation or indicate which additional industries may be targeted for immediate review. While the ruling changes the standard for litigation, specific dates for future state actions or potential defenses from industry groups have not been established.